Less frequent natalizumab (Tysabri)

Extending infusions of natalizumab (Tysabri) to every eight weeks was just as effective as every four weeks according to a study presented at the American Academy of Neurology (AAN) meeting. Newswise Natalizumab (Tysabri) - A to Z of MS
Source: Multiple Sclerosis Trust - Category: Neurology Source Type: news